[Inflammatory cytokines].
Mantovani
A
A
Dipartimento di Immunologia e Biologia Cellulare, Istituto di Ricerche Farmacologiche Mario Negri, Milano.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy; D054428:Chemokine CX3CL1; D018925:Chemokines / Q000276:immunology / Q000502:physiology; D020523:Chemokines, CX3C; D019743:Chemokines, CXC / Q000502:physiology; D003424:Crohn Disease / Q000188:drug therapy; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D007962:Leukocytes / Q000276:immunology; D008565:Membrane Proteins / Q000502:physiology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology; D012106:Research; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology
C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1; D018925:Chemokines; D020523:Chemokines, CX3C; D019743:Chemokines, CXC; D016207:Cytokines; D007375:Interleukin-1; D008565:Membrane Proteins; D017472:Receptors, Interleukin-1; D014409:Tumor Necrosis Factor-alpha